01:34 PM EDT, 03/11/2024 (MT Newswires) -- Health care stocks fell Monday afternoon with the NYSE Health Care Index decreasing 0.3% and the Health Care Select Sector SPDR Fund (XLV) down 0.1%.

The iShares Biotechnology ETF (IBB) rose 0.3%.

In corporate news, Mesoblast (MESO) shares surged 23% after the company said that the US Food and Drug Administration supports an accelerated approval for its rexlemestrocel-L cell therapy in end-stage heart failure patients with a left ventricular assist device.